BMO Capital Maintains Positive Long-Term Outlook for Vital Farms (VITL) Despite Temporary 2025 Revision

Group 1 - Vital Farms Inc. (NASDAQ:VITL) is considered an oversold stock with potential for recovery, despite a downward revision of its 2025 outlook [1][2] - BMO Capital has lowered its price target for Vital Farms to $50 from $60 while maintaining an Outperform rating, citing that the 2025 revision reflects temporary disruptions [1] - Morgan Stanley also reduced its price target to $45 from $48 but maintained an Overweight rating, noting that the company's long-term targets exceeded analyst expectations [2] Group 2 - Needham initiated coverage of Vital Farms with a Buy rating and a $45 price target, highlighting the company's strong volume-driven earnings fundamentals [3] - The long-term revenue CAGR for Vital Farms is expected to be in the low 20% range, indicating a positive outlook despite short-term challenges [1] - The company's recent Investor Day revealed management's updated long-term algorithm, which was overshadowed by the unexpected cut to 2025 revenue guidance [2]